Form 4: GeoVax Labs CEO Acquires Stock Options
SEC Form 4 Filing
GeoVax Labs CEO, David A. Dodd, reports the acquisition of stock options.
Summary
- David A. Dodd, the President and CEO of GeoVax Labs, Inc., filed a Form 4.
- The filing reports a transaction that occurred on August 12, 2024.
- Dodd acquired 35,000 stock options with an exercise price of $2.17.
- The stock options become exercisable in three equal annual installments starting on the first anniversary of the grant date.
- The options expire on August 12, 2034.
- Following the reported transaction, Dodd beneficially owns 35,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing. The sentiment is neutral as it simply reports a transaction.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- The acquisition of stock options by the CEO could potentially align management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of stock option grant and transaction. |
| 08/14/2024 | Date of Form 4 filing. |
| 08/12/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.